ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2024
When AI Writes Back: Ethical Considerations by Physicians on AI-Drafted Patient Message Replies.
Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A scoping review of studies on secure messaging through patient portals: persistent challenges and potential solutions.npj health systems · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The increasing burden of responding to large volumes of patient messages has become a key factor contributing to physician burnout. Generative AI (GenAI) shows great promise to alleviate this burden by automatically drafting patient message replies. The ethical implications of this use have however not been fully explored. To address this knowledge gap, we conducted a qualitative interview study with 21 physicians who participated in a GenAI pilot program. We found that notable ethical considerations expressed by the physician participants included oversight as ethical safeguard, transparency and patient consent of AI use, patient misunderstanding of AI's role, and patient privacy and data security as prerequisites. Additionally, our findings suggest that the physicians believe the ethical responsibility of using GenAI in this context primarily lies with users, not with the technology. These findings may provide useful insights into guiding the future implementation of GenAI in clinical practice.
Indexed as
Identifiers
41726446PMC12919555What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.